A RETROSPECTIVE STUDY ON PREVALANCE OF ANEMIA IN PREGNANCY IN A TERITIARY CARE HOSPITAL

Authors

  • SYEDA ZAINEB KUBRA HUSSAINI Department of Pharmacy Practice, Malla Reddy Pharmacy College, Hyderabad, Telangana, India.
  • BUSHRA SHEREEN Department of Obstetrics and Gynecology, Malla Reddy Narayana Multispeciality Hospital, Hyderabad, India.
  • SIRISHA D Department of Pharmacy Practice, Malla Reddy Pharmacy College, Hyderabad, Telangana, India.
  • MADHAVI E Department of Pharmacy Practice, Malla Reddy Pharmacy College, Hyderabad, Telangana, India.
  • HARI PRIYA E Department of Pharmacy Practice, Malla Reddy Pharmacy College, Hyderabad, Telangana, India.
  • HIMABINDU G Department of Pharmacy Practice, Malla Reddy Pharmacy College, Hyderabad, Telangana, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i9.42327

Keywords:

Anemia, Hemoglobin, Gravidity, Period of gestation

Abstract

Objective: To study about prevalence in anemia among the antenatal women, its clinical features, and access the severity and its treatment response.

Methods: A hospital-based retrospective study on the prevalence of anemia among the antenatal women in tertiary care hospital for 6 months duration in gynecology and obstetrics department. In evaluating pregnant women with anemia, it is essential to do a complete history and physical examination, as well as complete blood count with indices and a blood smear examination. Based on these findings, other test such as ferritin and serum or red cell folate may be ordered. Because of normal physiologic changes in pregnancy that effect the hematocrit, indices, and some other parameters, diagnosing true anemia, as well as the etiology of anemia, is challenging.

Results and Discussion: In this retrospective study, the prevalence of Anemia in pregnancy in a tertiary care hospital was evaluated and determined in fifty patients. The most common age group was between 21 and 25 years i.e., (21 patients) 42%. Among 50 patients, majority of them, i.e., 35 patients (70%) were treated with Injection. Iron Sucrose (200 mg). In this study, increase in prevalence were seen majorly in the third trimester, i.e., 25 patients (50%) of which 22 patients (88%) were with moderate anemia with 7.9 gm/dl average hemoglobin (Hb) percentage and 3 patients (12%) were with mild anemia with 9.3 gm/dl average Hb percentage.

Conclusion: The plan of management for anemia complicating pregnancy depends on the type of anemia. Oral iron therapy is the route of choice in women with mild to moderate anemia and for severe anemia in pregnant women <30 weeks of gestation. The rise of Hb with parenteral iron therapy is almost the same (avg: 1gm/dl/week) as that of oral iron therapy.

Downloads

Download data is not yet available.

References

Vanderjagt DJ, Brock HS, Melah GS, El-Nafaty AU, Crossey MJ, Glew RH. Nutritional factors associated with anaemia in pregnant women in Northern Nigeria.J Health Popul Nutr 2007;25:75-8.

DeMayor EM, Tegman A. Prevalence of anaemia in the world. World Health Stat Q 1998;38:302-16.

Kalaivani K. Prevalence and consequences of anaemia in pregnancy. Indian J Med Res 2009;130:627-33.

NFHS-4, 2015-16; 2016. Available from: http://www.rchiips.org/nfhs/ pdf/nfhs4/india.pdf. [Last accessed on 2020 Jul 12].

Camargo RM, Pereira RA, Yokoo EM, Schirmer J. Factors associated with iron deficiency in pregnant women seen at a public prenatal care service. Rev Nutr 2013;26:455-64.

Brabin B, Sapau J, Galme K, Paino J. Consequences of maternal anaemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea. Ann Trop Med Parasitol 1990;84:11-24.

Rammohan A, Awofeso N, Robitaille MC. Addressing female iron-deficiency anaemia in India: Is vegetarianism the major obstacle? ISRN Public Health 2012;2012:765476.

Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: Iron, cobalamin, and folate. Blood 2017;129:940-9.

World Health Organization. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience. Geneva, Switzerland: World Health Organization; 2016.

Ortiz R, Toblli JE, Romero JD, Monterrosa B, Frer C, Macagno E, et al. Efficacy and safety of oral iron (III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: A multicenter, randomized, controlled study. J Matern Fetal Neonatal Med 2011;24:1347-52.

Camaschella C. Iron deficiency: New insights into diagnosis and treatment. Hematology Am Soc Hematol Educ Program 2015;2015:8-13.

Koch TA, Myers J, Goodnough LT. Intravenous iron therapy in patients with iron deficiency anemia: Dosing considerations. Anemia 2015;2015:763576

Published

06-09-2021

How to Cite

KUBRA HUSSAINI, S. Z., B. SHEREEN, S. D, M. E, H. P. E, and H. G. “A RETROSPECTIVE STUDY ON PREVALANCE OF ANEMIA IN PREGNANCY IN A TERITIARY CARE HOSPITAL”. Asian Journal of Pharmaceutical and Clinical Research, vol. 14, no. 9, Sept. 2021, pp. 106-8, doi:10.22159/ajpcr.2021.v14i9.42327.

Issue

Section

Original Article(s)